• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Therapeutic Area
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global cancer supportive care market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global cancer supportive care market 2017 – 2021 ($ million)
o 4.2 Therapeutic area Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Therapeutic area Segment 2017 – 2021 ($ million)
o 4.3 Distribution channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Therapeutic Area
o 6.1 Market segments
o Exhibit 30: Chart on Therapeutic Area – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Therapeutic Area – Market share 2022-2027 (%)
o 6.2 Comparison by Therapeutic Area
o Exhibit 32: Chart on Comparison by Therapeutic Area
o Exhibit 33: Data Table on Comparison by Therapeutic Area
o 6.3 Chemotherapy-induced anemia – Market size and forecast 2022-2027
o Exhibit 34: Chart on Chemotherapy-induced anemia – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Chemotherapy-induced anemia – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Chemotherapy-induced anemia – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Chemotherapy-induced anemia – Year-over-year growth 2022-2027 (%)
o 6.4 Chemotherapy-induced neutropenia – Market size and forecast 2022-2027
o Exhibit 38: Chart on Chemotherapy-induced neutropenia – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Chemotherapy-induced neutropenia – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Chemotherapy-induced neutropenia – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Chemotherapy-induced neutropenia – Year-over-year growth 2022-2027 (%)
o 6.5 Cancer pain – Market size and forecast 2022-2027
o Exhibit 42: Chart on Cancer pain – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Cancer pain – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Cancer pain – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Cancer pain – Year-over-year growth 2022-2027 (%)
o 6.6 CINV – Market size and forecast 2022-2027
o Exhibit 46: Chart on CINV – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on CINV – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on CINV – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on CINV – Year-over-year growth 2022-2027 (%)
o 6.7 Others – Market size and forecast 2022-2027
o Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Therapeutic Area
o Exhibit 54: Market opportunity by Therapeutic Area ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 55: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 56: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 57: Chart on Comparison by Distribution Channel
o Exhibit 58: Data Table on Comparison by Distribution Channel
o 7.3 Hospitals pharmacies – Market size and forecast 2022-2027
o Exhibit 59: Chart on Hospitals pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Hospitals pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Hospitals pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Hospitals pharmacies – Year-over-year growth 2022-2027 (%)
o 7.4 Drug stores and retail pharmacies – Market size and forecast 2022-2027
o Exhibit 63: Chart on Drug stores and retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Drug stores and retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Drug stores and retail pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Drug stores and retail pharmacies – Year-over-year growth 2022-2027 (%)
o 7.5 Online providers – Market size and forecast 2022-2027
o Exhibit 67: Chart on Online providers – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Online providers – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Online providers – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Online providers – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 71: Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 73: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 75: Chart on Geographic comparison
o Exhibit 76: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 77: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 81: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 85: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 89: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 93: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 97: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 101: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 105: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 Canada – Market size and forecast 2022-2027
o Exhibit 109: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 110: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 111: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 112: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 113: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 114: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 116: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 117: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 118: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 119: Matrix on vendor position and classification
o 12.3 Amgen Inc.
o Exhibit 120: Amgen Inc. – Overview
o Exhibit 121: Amgen Inc. – Product / Service
o Exhibit 122: Amgen Inc. – Key offerings
o 12.4 Baxter International Inc.
o Exhibit 123: Baxter International Inc. – Overview
o Exhibit 124: Baxter International Inc. – Business segments
o Exhibit 125: Baxter International Inc. – Key news
o Exhibit 126: Baxter International Inc. – Key offerings
o Exhibit 127: Baxter International Inc. – Segment focus
o 12.5 Bayer AG
o Exhibit 128: Bayer AG – Overview
o Exhibit 129: Bayer AG – Business segments
o Exhibit 130: Bayer AG – Key news
o Exhibit 131: Bayer AG – Key offerings
o Exhibit 132: Bayer AG – Segment focus
o 12.6 Daiichi Sankyo Co. Ltd.
o Exhibit 133: Daiichi Sankyo Co. Ltd. – Overview
o Exhibit 134: Daiichi Sankyo Co. Ltd. – Business segments
o Exhibit 135: Daiichi Sankyo Co. Ltd. – Key news
o Exhibit 136: Daiichi Sankyo Co. Ltd. – Key offerings
o Exhibit 137: Daiichi Sankyo Co. Ltd. – Segment focus
o 12.7 F. Hoffmann La Roche Ltd.
o Exhibit 138: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 139: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 140: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 141: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 142: F. Hoffmann La Roche Ltd. – Segment focus
o 12.8 GlaxoSmithKline Plc
o Exhibit 143: GlaxoSmithKline Plc – Overview
o Exhibit 144: GlaxoSmithKline Plc – Business segments
o Exhibit 145: GlaxoSmithKline Plc – Key offerings
o Exhibit 146: GlaxoSmithKline Plc – Segment focus
o 12.9 Heron Therapeutics Inc.
o Exhibit 147: Heron Therapeutics Inc. – Overview
o Exhibit 148: Heron Therapeutics Inc. – Product / Service
o Exhibit 149: Heron Therapeutics Inc. – Key news
o Exhibit 150: Heron Therapeutics Inc. – Key offerings
o 12.10 Johnson and Johnson
o Exhibit 151: Johnson and Johnson – Overview
o Exhibit 152: Johnson and Johnson – Business segments
o Exhibit 153: Johnson and Johnson – Key news
o Exhibit 154: Johnson and Johnson – Key offerings
o Exhibit 155: Johnson and Johnson – Segment focus
o 12.11 Kyowa Kirin Co. Ltd.
o Exhibit 156: Kyowa Kirin Co. Ltd. – Overview
o Exhibit 157: Kyowa Kirin Co. Ltd. – Product / Service
o Exhibit 158: Kyowa Kirin Co. Ltd. – Key offerings
o 12.12 Merck and Co. Inc.
o Exhibit 159: Merck and Co. Inc. – Overview
o Exhibit 160: Merck and Co. Inc. – Business segments
o Exhibit 161: Merck and Co. Inc. – Key news
o Exhibit 162: Merck and Co. Inc. – Key offerings
o Exhibit 163: Merck and Co. Inc. – Segment focus
o 12.13 Novartis AG
o Exhibit 164: Novartis AG – Overview
o Exhibit 165: Novartis AG – Business segments
o Exhibit 166: Novartis AG – Key offerings
o Exhibit 167: Novartis AG – Segment focus
o 12.14 Purdue Pharma LP
o Exhibit 168: Purdue Pharma LP – Overview
o Exhibit 169: Purdue Pharma LP – Product / Service
o Exhibit 170: Purdue Pharma LP – Key offerings
o 12.15 Sanofi SA
o Exhibit 171: Sanofi SA – Overview
o Exhibit 172: Sanofi SA – Business segments
o Exhibit 173: Sanofi SA – Key news
o Exhibit 174: Sanofi SA – Key offerings
o Exhibit 175: Sanofi SA – Segment focus
o 12.16 Sun Pharmaceutical Industries Ltd.
o Exhibit 176: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 177: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 178: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.17 Teva Pharmaceutical Industries Ltd.
o Exhibit 179: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 180: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 181: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 182: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 183: Teva Pharmaceutical Industries Ltd. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 184: Inclusions checklist
o Exhibit 185: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 186: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 187: Research methodology
o Exhibit 188: Validation techniques employed for market sizing
o Exhibit 189: Information sources
o 13.5 List of abbreviations
o Exhibit 190: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Therapeutic Area
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global cancer supportive care market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Therapeutic area Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Therapeutic Area – Market share 2022-2027 (%)
Exhibits31: Data Table on Therapeutic Area – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapeutic Area
Exhibits33: Data Table on Comparison by Therapeutic Area
Exhibits34: Chart on Chemotherapy-induced anemia – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Chemotherapy-induced anemia – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Chemotherapy-induced anemia – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Chemotherapy-induced anemia – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Chemotherapy-induced neutropenia – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Chemotherapy-induced neutropenia – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Chemotherapy-induced neutropenia – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Chemotherapy-induced neutropenia – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Cancer pain – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Cancer pain – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Cancer pain – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Cancer pain – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on CINV – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on CINV – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on CINV – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on CINV – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Therapeutic Area ($ million)
Exhibits55: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits56: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by Distribution Channel
Exhibits58: Data Table on Comparison by Distribution Channel
Exhibits59: Chart on Hospitals pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Hospitals pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Hospitals pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Hospitals pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Drug stores and retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Drug stores and retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Drug stores and retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Drug stores and retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Online providers – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Online providers – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Online providers – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Online providers – Year-over-year growth 2022-2027 (%)
Exhibits71: Market opportunity by Distribution Channel ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits109: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits110: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits111: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits112: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits113: Market opportunity By Geographical Landscape ($ million)
Exhibits114: Impact of drivers and challenges in 2022 and 2027
Exhibits115: Overview on Criticality of inputs and Factors of differentiation
Exhibits116: Overview on factors of disruption
Exhibits117: Impact of key risks on business
Exhibits118: Vendors covered
Exhibits119: Matrix on vendor position and classification
Exhibits120: Amgen Inc. – Overview
Exhibits121: Amgen Inc. – Product / Service
Exhibits122: Amgen Inc. – Key offerings
Exhibits123: Baxter International Inc. – Overview
Exhibits124: Baxter International Inc. – Business segments
Exhibits125: Baxter International Inc. – Key news
Exhibits126: Baxter International Inc. – Key offerings
Exhibits127: Baxter International Inc. – Segment focus
Exhibits128: Bayer AG – Overview
Exhibits129: Bayer AG – Business segments
Exhibits130: Bayer AG – Key news
Exhibits131: Bayer AG – Key offerings
Exhibits132: Bayer AG – Segment focus
Exhibits133: Daiichi Sankyo Co. Ltd. – Overview
Exhibits134: Daiichi Sankyo Co. Ltd. – Business segments
Exhibits135: Daiichi Sankyo Co. Ltd. – Key news
Exhibits136: Daiichi Sankyo Co. Ltd. – Key offerings
Exhibits137: Daiichi Sankyo Co. Ltd. – Segment focus
Exhibits138: F. Hoffmann La Roche Ltd. – Overview
Exhibits139: F. Hoffmann La Roche Ltd. – Business segments
Exhibits140: F. Hoffmann La Roche Ltd. – Key news
Exhibits141: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits142: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits143: GlaxoSmithKline Plc – Overview
Exhibits144: GlaxoSmithKline Plc – Business segments
Exhibits145: GlaxoSmithKline Plc – Key offerings
Exhibits146: GlaxoSmithKline Plc – Segment focus
Exhibits147: Heron Therapeutics Inc. – Overview
Exhibits148: Heron Therapeutics Inc. – Product / Service
Exhibits149: Heron Therapeutics Inc. – Key news
Exhibits150: Heron Therapeutics Inc. – Key offerings
Exhibits151: Johnson and Johnson – Overview
Exhibits152: Johnson and Johnson – Business segments
Exhibits153: Johnson and Johnson – Key news
Exhibits154: Johnson and Johnson – Key offerings
Exhibits155: Johnson and Johnson – Segment focus
Exhibits156: Kyowa Kirin Co. Ltd. – Overview
Exhibits157: Kyowa Kirin Co. Ltd. – Product / Service
Exhibits158: Kyowa Kirin Co. Ltd. – Key offerings
Exhibits159: Merck and Co. Inc. – Overview
Exhibits160: Merck and Co. Inc. – Business segments
Exhibits161: Merck and Co. Inc. – Key news
Exhibits162: Merck and Co. Inc. – Key offerings
Exhibits163: Merck and Co. Inc. – Segment focus
Exhibits164: Novartis AG – Overview
Exhibits165: Novartis AG – Business segments
Exhibits166: Novartis AG – Key offerings
Exhibits167: Novartis AG – Segment focus
Exhibits168: Purdue Pharma LP – Overview
Exhibits169: Purdue Pharma LP – Product / Service
Exhibits170: Purdue Pharma LP – Key offerings
Exhibits171: Sanofi SA – Overview
Exhibits172: Sanofi SA – Business segments
Exhibits173: Sanofi SA – Key news
Exhibits174: Sanofi SA – Key offerings
Exhibits175: Sanofi SA – Segment focus
Exhibits176: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits177: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits178: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits179: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits180: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits181: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits182: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits183: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits184: Inclusions checklist
Exhibits185: Exclusions checklist
Exhibits186: Currency conversion rates for US$
Exhibits187: Research methodology
Exhibits188: Validation techniques employed for market sizing
Exhibits189: Information sources
Exhibits190: List of abbreviations